Eloisa Martins da Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eloisa Martins da Silva has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Marcella Cipelli
Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
2 shared publications - Mariana Abrantes Do Amaral
Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, Av. Professor Lineu Prestes 1730, ICB IV, Butantã, São Paulo 05508-000, Brazil
2 shared publications - Niels Olsen Saraiva Câmara
Federal University of São Paulo
2 shared publications - Vinicius Andrade-Oliveira
Mucosal Health and Immunity Laboratory (MHIL), Center for Natural and Human Sciences (CCNH), Federal Universityof ABC (UFABC), Santo André, São Paulo, Brazil
2 shared publications - Alvaro Pacheco-Silva
Department of Nephrology, Paulista School of Medicine, Federal University of São Paulo, Pedro de Toledo Street, 669, Vila Clementino – São Paulo, 04039-032, SP, Brazil, Brazil
1 shared publication - Alvaro Pacheco-Silva
Department of Nephrology, Paulista School of Medicine, Federal University of São Paulo, Pedro de Toledo Street, 669, Vila Clementino, São Paulo 04039-032, Brazil
1 shared publication
Latest Publications
- Open Access
- 18 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (22) , 11127
Downregulation of Enteroendocrine Genes Predicts Survival in Colon Cancer: A Bioinformatics-Based Analysis
Colorectal cancer (CRC) is the fourth most common and the third mostly deadly cancer globally. Even with alternative therapies, some patients do not respond to treatment. Identifying modulations in the tumor microenvironment (TME) of CRC is a significant challenge due to the complex and dynamic nature of the TME. The intestinal epithelium comprises different types of secretory lineage cells, including goblet, tuft, Paneth, and enteroendocrine cells (EECs). Yet the relevance of each subtype of secretory intestinal epithelial cell (IEC) within the TME is still debated. This study investigated the involvement of IECs in CRC development through an integrative bioinformatics analysis. We used publicly available datasets from the National Center for Biotechnology Information, the Cancer Genome Atlas Program, and the National Cancer Institute’s Proteomics Tumor Analysis Consortium, encompassing both human and mouse CRC samples. Our findings reveal a CRC microenvironment characterized by elevated expression levels of genes associated with WNT pathway activity. Remarkably, there was increased expression of Paneth cell-associated markers and transcription factors, such as WISP1, LYZ, SOX9, and DEFA1. Conversely, EEC-specific gene markers, such as GCG (encoding glucagon-like peptide-1) and CHGA exhibited significant downregulation in CRC tissue compared with healthy tissue, partially due to Paneth cell activity. Gene ontology analysis showed species-conserved downregulation in hormone/peptide secretion-related pathways in both mouse and human CRC. Of note, lower levels of GCG and CHGA correlated with reduced overall survival and demonstrated a correlation with the cell cycle, apoptosis, and proliferation. These results suggest that the disruption of enteroendocrine cell signaling is a hallmark of CRC development and may hold prognostic and therapeutic value in treating CRC patients.
- 18 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (22) , 11127
Open AccessDownregulation of Enteroendocrine Genes Predicts Survival in Colon Cancer: A Bioinformatics-Based Analysis
Colorectal cancer (CRC) is the fourth most common and the third mostly deadly cancer globally. Even with alternative therapies, some patients do not respond to treatment. Identifying modulations in the tumor microenvironment (TME) of CRC is a significant challenge due to the complex and dynamic nature of the TME. The intestinal epithelium comprises different types of secretory lineage cells, including goblet, tuft, Paneth, and enteroendocrine cells (EECs). Yet the relevance of each subtype of secretory intestinal epithelial cell (IEC) within the TME is still debated. This study investigated the involvement of IECs in CRC development through an integrative bioinformatics analysis. We used publicly available datasets from the National Center for Biotechnology Information, the Cancer Genome Atlas Program, and the National Cancer Institute’s Proteomics Tumor Analysis Consortium, encompassing both human and mouse CRC samples. Our findings reveal a CRC microenvironment characterized by elevated expression levels of genes associated with WNT pathway activity. Remarkably, there was increased expression of Paneth cell-associated markers and transcription factors, such as WISP1, LYZ, SOX9, and DEFA1. Conversely, EEC-specific gene markers, such as GCG (encoding glucagon-like peptide-1) and CHGA exhibited significant downregulation in CRC tissue compared with healthy tissue, partially due to Paneth cell activity. Gene ontology analysis showed species-conserved downregulation in hormone/peptide secretion-related pathways in both mouse and human CRC. Of note, lower levels of GCG and CHGA correlated with reduced overall survival and demonstrated a correlation with the cell cycle, apoptosis, and proliferation. These results suggest that the disruption of enteroendocrine cell signaling is a hallmark of CRC development and may hold prognostic and therapeutic value in treating CRC patients.
- Open Access
- 6 October 2025
- Published by MDPI AG in Preprints.org
Downregulation of Enteroendocrine Genes Predicts Survival in Colon Cancer: A Bioinformatics-Based Analysis
Colorectal cancer (CRC) is the fourth and the third most common and deadlycancer, respectively, worldwide. Even with alternative therapies, some patients do notrespond to treatment. Identifying modulations in the tumor microenvironment (TME) ofCRC is indeed a challenge due to the complex and dynamic nature of the TME. Theintestinal epithelial cells (IECs) are composed by different types of secretory-lineagecells, such as goblet, tuft, paneth and enteroendocrine cells (EECs). Yet, the relevanceof each subtype of secretory IEC in the tumor microenvironment is still a matter of debate.This study investigated the involvement of IECs in CRC through an integrativebioinformatics analysis using publicly available datasets from National Center forBiotechnology Information (NCBI) and The Cancer Genome Atlas Program (TCGA),encompassing both human and mouse CRC samples. Our findings reveal a CRC TMEfeatured by elevated expression levels of genes associated with WNT pathway activity.Remarkably, there was an increased expression of Paneth cell-associated markers andtranscription factors, such as WISP1, LYZ, SOX9, and DEFA1 while enteroendocrinecells-specific gene markers, such as GCG (encoding Glucagon like Peptide-1) andCHGA exhibited a significant downregulation in CRC tissue compared with health tissue.Gene ontology (GO) analysis showed a species-conserved downregulation inhormone/peptide secretion-related pathways of CRC in mouse and human. Of note,lower levels of GCG and CHGA correlated with reduced overall survival andchemotherapy-unresponsive patients. These results suggest that disruption of EECsignaling is a hallmark of CRC development and may hold prognostic and therapeuticvalue for treating CRC patients.
- 6 October 2025
- Published by MDPI AG in Preprints.org
Open AccessDownregulation of Enteroendocrine Genes Predicts Survival in Colon Cancer: A Bioinformatics-Based Analysis
Colorectal cancer (CRC) is the fourth and the third most common and deadlycancer, respectively, worldwide. Even with alternative therapies, some patients do notrespond to treatment. Identifying modulations in the tumor microenvironment (TME) ofCRC is indeed a challenge due to the complex and dynamic nature of the TME. Theintestinal epithelial cells (IECs) are composed by different types of secretory-lineagecells, such as goblet, tuft, paneth and enteroendocrine cells (EECs). Yet, the relevanceof each subtype of secretory IEC in the tumor microenvironment is still a matter of debate.This study investigated the involvement of IECs in CRC through an integrativebioinformatics analysis using publicly available datasets from National Center forBiotechnology Information (NCBI) and The Cancer Genome Atlas Program (TCGA),encompassing both human and mouse CRC samples. Our findings reveal a CRC TMEfeatured by elevated expression levels of genes associated with WNT pathway activity.Remarkably, there was an increased expression of Paneth cell-associated markers andtranscription factors, such as WISP1, LYZ, SOX9, and DEFA1 while enteroendocrinecells-specific gene markers, such as GCG (encoding Glucagon like Peptide-1) andCHGA exhibited a significant downregulation in CRC tissue compared with health tissue.Gene ontology (GO) analysis showed a species-conserved downregulation inhormone/peptide secretion-related pathways of CRC in mouse and human. Of note,lower levels of GCG and CHGA correlated with reduced overall survival andchemotherapy-unresponsive patients. These results suggest that disruption of EECsignaling is a hallmark of CRC development and may hold prognostic and therapeuticvalue for treating CRC patients.